Search

Sandra E. Saucier

Examiner (ID: 1842)

Most Active Art Unit
1651
Art Unit(s)
1651, 1808, 1657
Total Applications
1461
Issued Applications
816
Pending Applications
208
Abandoned Applications
438

Applications

Application numberTitle of the applicationFiling DateStatus
09/290846 HEMOSTATIC POLYMER USEFUL FOR RAPID BLOOD COAGULATION AND HEMOSTASIS Apr 12, 1999 Abandoned
Array ( [id] => 4415660 [patent_doc_number] => 06194137 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'Method of cryopreservation of blood vessels by vitrification' [patent_app_type] => 1 [patent_app_number] => 9/289977 [patent_app_country] => US [patent_app_date] => 1999-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 7175 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/194/06194137.pdf [firstpage_image] =>[orig_patent_app_number] => 289977 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/289977
Method of cryopreservation of blood vessels by vitrification Apr 12, 1999 Issued
Array ( [id] => 4274261 [patent_doc_number] => 06281003 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-28 [patent_title] => 'Enzymatic synthesis of optically active hydroxamic acids and their conversion to optically active primary amines by a lossen rearrangement' [patent_app_type] => 1 [patent_app_number] => 9/180747 [patent_app_country] => US [patent_app_date] => 1999-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6937 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/281/06281003.pdf [firstpage_image] =>[orig_patent_app_number] => 180747 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/180747
Enzymatic synthesis of optically active hydroxamic acids and their conversion to optically active primary amines by a lossen rearrangement Apr 4, 1999 Issued
09/268405 RED BLOOD CELL STORAGE SOLUTION Mar 14, 1999 Abandoned
09/171053 STORAGE OF MATERIALS Mar 14, 1999 Abandoned
Array ( [id] => 4085702 [patent_doc_number] => 06133018 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Enzymatic synthesis of chiral amines using -2-amino propane as amine donor' [patent_app_type] => 1 [patent_app_number] => 9/266100 [patent_app_country] => US [patent_app_date] => 1999-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2739 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133018.pdf [firstpage_image] =>[orig_patent_app_number] => 266100 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/266100
Enzymatic synthesis of chiral amines using -2-amino propane as amine donor Mar 9, 1999 Issued
Array ( [id] => 6095623 [patent_doc_number] => 20020051963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'SHELF PRESERVATION OF CELLS, TISSUES, ORGANS AND ORGANISMS BY VITRIFICATION' [patent_app_type] => new [patent_app_number] => 09/254563 [patent_app_country] => US [patent_app_date] => 1999-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4366 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20020051963.pdf [firstpage_image] =>[orig_patent_app_number] => 09254563 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/254563
SHELF PRESERVATION OF CELLS, TISSUES, ORGANS AND ORGANISMS BY VITRIFICATION Mar 4, 1999 Abandoned
Array ( [id] => 4266299 [patent_doc_number] => 06322785 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-27 [patent_title] => 'Methods and compositions for bone graft implants' [patent_app_type] => 1 [patent_app_number] => 9/261291 [patent_app_country] => US [patent_app_date] => 1999-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2893 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/322/06322785.pdf [firstpage_image] =>[orig_patent_app_number] => 261291 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/261291
Methods and compositions for bone graft implants Mar 1, 1999 Issued
Array ( [id] => 4085446 [patent_doc_number] => 06133001 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Stereoselective microbial reduction for the preparation of 1-(4-fluorophenyl)-3(R)-[3(S)-Hydroxy-3-(4-fluorophenyl)propyl)]-4(S)-(4 -hydroxyphenyl)-2-azetidinone' [patent_app_type] => 1 [patent_app_number] => 9/256029 [patent_app_country] => US [patent_app_date] => 1999-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2494 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133001.pdf [firstpage_image] =>[orig_patent_app_number] => 256029 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/256029
Stereoselective microbial reduction for the preparation of 1-(4-fluorophenyl)-3(R)-[3(S)-Hydroxy-3-(4-fluorophenyl)propyl)]-4(S)-(4 -hydroxyphenyl)-2-azetidinone Feb 22, 1999 Issued
Array ( [id] => 4380027 [patent_doc_number] => 06277626 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Process for the enzymatic resolution of lactams' [patent_app_type] => 1 [patent_app_number] => 9/250197 [patent_app_country] => US [patent_app_date] => 1999-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7054 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277626.pdf [firstpage_image] =>[orig_patent_app_number] => 250197 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/250197
Process for the enzymatic resolution of lactams Feb 15, 1999 Issued
Array ( [id] => 4351514 [patent_doc_number] => 06218099 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-17 [patent_title] => 'Methods and compositions for use in perfusion applications' [patent_app_type] => 1 [patent_app_number] => 9/244283 [patent_app_country] => US [patent_app_date] => 1999-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8961 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/218/06218099.pdf [firstpage_image] =>[orig_patent_app_number] => 244283 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/244283
Methods and compositions for use in perfusion applications Feb 2, 1999 Issued
Array ( [id] => 4187635 [patent_doc_number] => 06153432 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => 'Methods for the differentiation of human preadipocytes into adipocytes' [patent_app_type] => 1 [patent_app_number] => 9/240029 [patent_app_country] => US [patent_app_date] => 1999-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 7880 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 263 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153432.pdf [firstpage_image] =>[orig_patent_app_number] => 240029 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/240029
Methods for the differentiation of human preadipocytes into adipocytes Jan 28, 1999 Issued
Array ( [id] => 6129727 [patent_doc_number] => 20020076782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'PURIFIED NITRIC OXIDE SYNTHASE' [patent_app_type] => new [patent_app_number] => 09/225426 [patent_app_country] => US [patent_app_date] => 1999-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15459 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20020076782.pdf [firstpage_image] =>[orig_patent_app_number] => 09225426 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/225426
PURIFIED NITRIC OXIDE SYNTHASE Jan 4, 1999 Abandoned
Array ( [id] => 4083149 [patent_doc_number] => 06162637 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-19 [patent_title] => 'Aspergillus niger which produces vanillic acid from ferulic acid' [patent_app_type] => 1 [patent_app_number] => 9/216031 [patent_app_country] => US [patent_app_date] => 1998-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4469 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/162/06162637.pdf [firstpage_image] =>[orig_patent_app_number] => 216031 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/216031
Aspergillus niger which produces vanillic acid from ferulic acid Dec 17, 1998 Issued
Array ( [id] => 4378884 [patent_doc_number] => 06277556 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Controlling donor blood characteristics' [patent_app_type] => 1 [patent_app_number] => 9/213214 [patent_app_country] => US [patent_app_date] => 1998-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 5172 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277556.pdf [firstpage_image] =>[orig_patent_app_number] => 213214 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/213214
Controlling donor blood characteristics Dec 16, 1998 Issued
Array ( [id] => 4244902 [patent_doc_number] => 06136591 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Bioresolution of N-acylazetidine-2-carboxylic acids' [patent_app_type] => 1 [patent_app_number] => 9/202431 [patent_app_country] => US [patent_app_date] => 1998-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4412 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/136/06136591.pdf [firstpage_image] =>[orig_patent_app_number] => 202431 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/202431
Bioresolution of N-acylazetidine-2-carboxylic acids Dec 14, 1998 Issued
Array ( [id] => 1596994 [patent_doc_number] => 06492494 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-10 [patent_title] => 'Method of making a fibrin sealant comprising alpha-2-antiplasmin' [patent_app_type] => B1 [patent_app_number] => 09/208352 [patent_app_country] => US [patent_app_date] => 1998-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6418 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 194 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/492/06492494.pdf [firstpage_image] =>[orig_patent_app_number] => 09208352 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/208352
Method of making a fibrin sealant comprising alpha-2-antiplasmin Dec 8, 1998 Issued
09/199541 ORGAN PRESERVATION SOLUTION CONTAINING PYRUVATE Nov 24, 1998 Abandoned
09/200023 COMPRISING AN AMMONIUM SALT Nov 24, 1998 Abandoned
Array ( [id] => 1588282 [patent_doc_number] => 06482584 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => 'Cyclic implant perfusion cleaning and passivation process' [patent_app_type] => B1 [patent_app_number] => 09/191232 [patent_app_country] => US [patent_app_date] => 1998-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9054 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482584.pdf [firstpage_image] =>[orig_patent_app_number] => 09191232 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/191232
Cyclic implant perfusion cleaning and passivation process Nov 12, 1998 Issued
Menu